TRADE SHOW

Greenwich Biosciences at AES 2019

Greenwich Biosciences is a trailblazer in groundbreaking epilepsy medication called Epidiolex, using FDA-approved Cannabidiol treatments. With over 20,000 success treatment stories across North America, they are industry leaders in providing positive results for families suffering from epilepsy. Their show presence is built around telling these success stories.

The show team was required to capture and sustain the attention of an audience of experts while providing them with thorough answers for all their questions. Our main solutions, among others, involved telling the patient stories via large format graphics around the exhibit space that could be seen from across the convention center. We also used interactive digital tables that engaged visitors by allowing them to learn in-depth information about the Epidiolex treatments. This layered experience formed the company’s largest show presence leading into the new year. Their booth refresh at the end of 2019 in Baltimore was the company’s largest event before seeing a rise from 12,000 to over 20,000 prescribing physicians.